PolySciTech Products In Literature
PLGA-PEG-azide from PolySciTech used in development of decorated nanoparticle for cancer immunotherapy
Cancer cells and tumors typically apply a wide variety of strategies to evade the human immune system which makes treatment of them very difficult. Induction of a targeted immune response against tumors and cancer cells can provide a promising opportunity to leverage the power of the human immune system toward the elimination of cancer. Researchers at the Chinese Academy of Sciences, Jiangnan University, and Shenzhen University (China) used mPEG-PLGA (AK102) and PLGA-PEG-N3 (AI091) from PolySciTech to create immunotherapy initiating nanoparticles by Pickering emulsion methodologies. This research holds promise to provide improved therapies against cancer. Read more: Du, Yiqun, Tiantian Song, Jie Wu, Xiao-Dong Gao, Guanghui Ma, Yuchen Liu, and Yufei Xia. "Engineering mannosylated pickering emulsions for the targeted delivery of multicomponent vaccines." Biomaterials 280 (2022): 121313.
|
|
Print what you want with the latest bioresorbable polymer technology. AKiNAfil™ bioresorbable PLGA polymers reformatted in standardized 1.7 mm filament are available in a variety of lengths. The PLGA polymers are co-formulated with FDA-GRAS and biocompatible acetyltriethylcitrate (ATEC) plasticizer for improved processability and biorelevant degradation properties to be used in a wide array of biomedical applications. |
|
|
Browse through our searchable list of research
that reference the use of PolySciTech products.
|
|
|
PolySciTech Division of Akina, Inc. (www.polyscitech.com) provides a wide array of biodegradable polymers and other research supplies. Visit our website to find out more.
|
|
|
|
